← Back
Data updated: Mar 10, 2026
ANDA REPOSITORY
Infectious DiseaseRespiratoryDermatology
ANDA REPOSITORY is a generic drug manufacturer focused on Infectious Disease, Respiratory, Dermatology.
1992
Since
21
Drugs
-
Trials
315
Approved (2yr)
Key Drugs
Recent Activity
PREGABALIN 2026-02-24
PREGABALIN 2026-02-23
Labeling
PREGABALIN 2026-02-23
Labeling
PREGABALIN 2026-02-23
Labeling
METHAZOLAMIDE 2026-02-09
PREGABALIN 2026-02-03
Labeling
PREGABALIN 2026-02-02
Labeling
PREGABALIN 2026-02-02
Labeling
PROPRANOLOL HYDROCHLORIDE 2026-01-27
METHYLPHENIDATE HYDROCHLORIDE 2026-01-15
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Infectious Disease 40%
4 drugs
Respiratory 20%
2 drugs
Dermatology 20%
2 drugs
Cardiovascular 10%
1 drugs
Neurology 10%
1 drugs
Pipeline Strength Pro
Loading...
Competitors Pro
LEDERLE big-pharma
Infectious Disease, Cardiovascular, Neurology, Dermatology, Respiratory
GE HEALTHCARE specialty
Infectious Disease, Neurology, Cardiovascular, Respiratory
APOTHECON specialty
Infectious Disease, Dermatology, Cardiovascular, Respiratory
Baxter specialty
Infectious Disease, Cardiovascular, Dermatology
PAI HOLDINGS PHARM big-pharma
Dermatology, Infectious Disease, Neurology, Cardiovascular
Active (15)
Discontinued (6)
Company Info
- First Approval
- 1992-10-26
- Latest
- 2025-12-22
- Applications
- 24